top of page

Search

U.S. Supreme Court deals big blow to pharmacy middlemen

leozini
Dec 11, 2020
1 min read

The U.S. Supreme Court on Thursday ruled 8-0 that states have broad powers to regulate powerful pharmacy middlemen without being preempted by federal law.

The case was brought by the $400-billion-a-year industry, known as “pharmacy benefit managers,” against the state of Arkansas over a 2015 law that set a minimum, market-based rate the middlemen had to reimburse pharmacists for the drugs they dispensed...

Read the full story >

Recent Posts

Experts weigh in on Trump reversing Biden's order to lower drug prices

During his presidency, Joe Biden had directed Medicare to look at ways to lower drug costs, including whether or not to impose a two...

FTC slams PBMs for boosting specialty drug prices at the expense of the U.S. health care system

PBMs are ‘charging enormous markups on dozens of lifesaving drugs,’ an agency official said. For the second time in less than a year, the...

‘Customers are panicking’; Pharmacists make their case for reining in pharmacy benefit managers

Pharmacy benefit managers, or PBMs, are squeezing independent pharmacies out of the drug market, according to pharmacists who recently...

Comments

bottom of page